FDA Inspection 1316850 — Novo Nordisk A/S

Novo Nordisk A/S — FEI 3003037054

The FDA completed an inspection of Novo Nordisk A/S on Apr 17, 2026 in Malov. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.